Study Finds Syphilis Treatment During Pregnancy Critical for Good Birth Outcomes
What: Untreated maternal syphilis increases risk of adverse birth outcomes.
Key Line: “Systematic strategies are needed to address gaps in screening and treatment.”
Study Finds Syphilis Treatment During Pregnancy Critical for Good Birth Outcomes
What: Untreated maternal syphilis increases risk of adverse birth outcomes.
Key Line: “Systematic strategies are needed to address gaps in screening and treatment.”
Women’s Health Network hopes to fill federal funding gaps with private dollars.
Luxury spa resort launches new “Inner Glow” retreat focused on hormone health and long-term wellness.
Women with endometriosis are more likely to face earlier surgical or natural menopause.
Maternie analysis shows $31M cut from women’s health research, especially maternal health.
An editorial calls for moving beyond reproductive-only focus in women’s health.
Study shows women over 70 who screened regularly were diagnosed earlier and had lower mortality.
Year-long birth control prescriptions could cut unintended pregnancies and save money, says R Street.
The Economist finds abortions have increased in some states *after* bans, thanks to telehealth and shield laws.
Estrogen’s role in the brain goes far beyond reproduction, NYT reports.
NIH insists WHI is funded, but federal contract officers haven’t been told.
Whole Women’s Health CEO explains why in-person care still matters.
State attempts to expand fertility coverage face opposition from cost and fetal personhood movements.
One-third of patients spend more than $50,000 on fertility treatments, according to a new survey.
SWHR warns proposed Trump budget would slash NIH and CDC funding.
WBUR spotlights MAP volunteers mailing abortion meds to banned states.
ADF targets birth control and IUD coverage in campaign to cut ties with ACOG.
A small increase in births among women in their 30s and 40s offsets younger declines.
Researchers call for standardized criteria to assess dangerous placenta conditions.
New research finds minor, temporary changes in menstrual cycle length post-vaccine.
Makary says he won’t act on mifepristone for now, but is “awaiting more data.”